Table 1.
Histopathological characteristics | N | Tumor classifications | N | ||
---|---|---|---|---|---|
Histological type | 154 | % | TNM classification | 154 | % |
ductal in situ | 3 | 1.9 | 0 | 3 | 1.9 |
ductal invasive | 135 | 87.7 | I | 28 | 18.2 |
lobular in situ | 0 | 0.0 | II | 89 | 57.8 |
lobular invasive | 7 | 4.5 | III | 34 | 22.1 |
mixed | 2 | 1.3 | |||
other | 7 | 4.5 | Tumor subtypes | 154 | % |
luminal A | 76 | 49.4 | |||
Tumor grade | 154 | % | luminal B | 38 | 24.7 |
grade 1 | 10 | 6.5 | luminala | 5 | 3.2 |
grade 2 | 54 | 35.1 | HER2 like | 13 | 8.4 |
grade 3 | 89 | 57.8 | triple negative | 20 | 13.0 |
missing | 1 | 0.6 | Missing | 2 | 1.3 |
Tumor size | 154 | % | |||
pTis | 3 | 1.9 | |||
pT1 | 48 | 31.2 | |||
pT2 | 100 | 64.9 | |||
pT3 | 3 | 1.9 | |||
pT4 | 0 | 0.0 | |||
Lymph node status | 154 | % | |||
pN0 | 73 | 47.4 | |||
pN1 | 47 | 30.5 | |||
pN2 | 23 | 14.9 | |||
pN3 | 11 | 7.1 | |||
Estrogen receptor | 154 | % | |||
negative | 34 | 22.1 | |||
positive | 119 | 77.3 | |||
missing | 1 | 0.6 | |||
Progesterone receptor | 154 | % | |||
negative | 58 | 37.7 | |||
positive | 95 | 61.7 | |||
missing | 1 | 0.6 | |||
HER2 | 154 | % | |||
negative | 113 | 73.4 | |||
positive | 34 | 22.1 | |||
missing | 7 | 4.5 |
luminal category refers to samples which were positive for both ER and PR but which HER2 status was not assessed.